bicalutamide has been researched along with Liver Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Egawa, S; Enei, Y; Fukuokaya, W; Hata, K; Iwamoto, Y; Kimura, T; Matsukawa, A; Miki, J; Miyajima, K; Mori, K; Obayashi, K; Onuma, H; Otsuka, T; Sakanaka, K; Sano, T; Shimomura, T; Suzuki, H; Tsuzuki, S; Yanagisawa, T | 1 |
| Cao, Q; Gong, Y; Gu, J; He, Z; Nie, H; Zhu, L | 1 |
| Duensing, S; Grüllich, C; Hadaschik, BA; Höfner, T; Hohenfellner, M; Jäger, D; Pahernik, S; Vallet, S | 1 |
| Baten, A; Blokx, WA; Hoogendam, A; Molenaar, JP | 1 |
| Farla, P; Hersmus, R; Houtsmuller, AB; Trapman, J | 1 |
| Inoue, T; Kamoto, T; Kinoshita, H; Nakamura, E; Ogawa, O; Segawa, T; Shimizu, Y; Yoshida, T | 1 |
1 review(s) available for bicalutamide and Liver Neoplasms
| Article | Year |
|---|---|
Development of carcinoid tumour in hormonally treated adenocarcinoma of the prostate.
Topics: Adenocarcinoma; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Carcinoid Tumor; Humans; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Neoplasms, Multiple Primary; Nitriles; Positron-Emission Tomography; Prostatic Neoplasms; Somatostatin; Tosyl Compounds | 2009 |
5 other study(ies) available for bicalutamide and Liver Neoplasms
| Article | Year |
|---|---|
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancer.
Topics: Abiraterone Acetate; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Comparative Effectiveness Research; Humans; Japan; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nitriles; Nonsteroidal Anti-Androgens; Prednisolone; Prognosis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Risk Assessment; Tosyl Compounds | 2022 |
Acetylcholine acts on androgen receptor to promote the migration and invasion but inhibit the apoptosis of human hepatocarcinoma.
Topics: Acetylcholine; Androgen Antagonists; Androgens; Anilides; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mecamylamine; Metribolone; Neoplasm Invasiveness; Nitriles; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Receptors, Cholinergic; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Tosyl Compounds; Transcription, Genetic; Up-Regulation | 2013 |
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
Topics: Aged; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cohort Studies; Disease-Free Survival; Docetaxel; Flutamide; Humans; Leuprolide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitriles; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Taxoids; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate | 2015 |
Antiandrogens prevent stable DNA-binding of the androgen receptor.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; Computer Simulation; DNA; DNA-Binding Proteins; DNA, Neoplasm; Flutamide; Green Fluorescent Proteins; Humans; Liver Neoplasms; Male; Metribolone; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Recombinant Fusion Proteins; Tosyl Compounds | 2005 |
Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient.
Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Cell Growth Processes; Exons; Humans; Liver Neoplasms; Male; Mice; Mice, SCID; Middle Aged; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; Transplantation, Heterologous | 2005 |